-+ 0.00%
-+ 0.00%
-+ 0.00%

SHANTON PHARMA RECEIVES EMA AND FDA PEDIATRIC STUDY WAIVERS FOR SAP-001 IN HYPERURICEMIA

Reuters·11/11/2026 13:00:54

Please log in to view news